Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07748221

Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders

ONCO-MinD is a multicentre, cross-sectional, non-interventional mixed-method study aimed at investigating healthcare providers' attitudes towards oncology patients with mental disorders in Italian cancer centres. The study will assess levels of mental health-related stigma among healthcare professionals and explore factors associated with these attitudes, including professional background, clinical setting, experience, and previous exposure to mental health conditions. Quantitative survey data collected using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC) will be integrated with qualitative findings from semi-structured interviews to provide a comprehensive understanding of how stigma may influence clinical relationships, decision-making processes, and equity of cancer care.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Centro Riferimento Oncologico CRO IRCCS, Aviano, Italy

Loading trial locations.

About this study

Background People living with mental disorders experience substantial health inequalities, including reduced life expectancy and higher mortality rates from physical illnesses, including cancer. In oncology settings, evidence suggests that patients with mental disorders are less likely to receive guideline-concordant treatment, are more likely to experience delays in diagnosis, and often have lower treatment adherence. Multiple factors contribute to these disparities, including patient-related, organisational, and healthcare provider-related determinants.

Among healthcare provider-related factors, stigma towards people with mental disorders may influence communication, therapeutic relationships, treatment decisions, and access to appropriate care. One particularly relevant mechanism is diagnostic overshadowing, whereby physical symptoms may be misattributed to a patient's psychiatric condition, potentially resulting in delayed diagnosis and suboptimal management. Despite growing recognition of these issues, limited evidence is available regarding stigma among oncology healthcare professionals, particularly within the Italian context.

Study Objectives The primary objective is to evaluate the level of stigma among healthcare professionals towards oncology patients with mental disorders.

Secondary objectives are:

To identify associations between stigma levels and individual or professional characteristics, including years of experience, professional role, clinical area, education, and previous personal or professional exposure to mental health conditions.

To explore healthcare professionals' experiences, perceptions, and attitudes towards caring for oncology patients with mental disorders.

To investigate potential barriers affecting clinical interactions and care pathways, including the role of diagnostic overshadowing and other stigma-related mechanisms.

Study Design

ONCO-MinD is a multicentre, observational, cross-sectional, non-interventional study using a sequential explanatory mixed-method design. The study consists of two consecutive and integrated phases:

Phase 1: Quantitative Component

Eligible healthcare professionals working in participating oncology centres will be invited to complete an anonymous electronic questionnaire through a secure REDCap platform. The questionnaire includes:

Socio-demographic and professional characteristics. The Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC), a validated instrument measuring stigma towards individuals with mental disorders.

The survey will remain available for approximately three months. Phase 2: Qualitative Component Following analysis of the quantitative findings, a purposive sample of healthcare professionals will be invited to participate in semi-structured interviews. Interviews will explore experiences, perceptions, barriers, facilitators, and the impact of mental health conditions on oncology care and clinical decision-making. Interviews will be audio-recorded, transcribed, anonymised, and analysed using thematic analysis.

Integration of Findings Quantitative and qualitative results will be integrated through a mixed-method approach using joint displays and meta-inferences. This strategy will allow a deeper understanding of the factors underlying stigma and its potential influence on cancer care delivery.

Study Population

The study population includes healthcare professionals directly involved in oncology care at participating centres, including:

Physicians Nurses Psychologists Radiation therapy technologists Healthcare assistants

All eligible professionals working within participating institutions will be invited to participate.

Participating Centres

Veneto Institute of Oncology (IOV-IRCCS), Padua, Italy Centro di Riferimento Oncologico (CRO-IRCCS), Aviano, Italy Istituto Tumori "Giovanni Paolo II" (IRCCS), Bari, Italy

Expected Impact The study is expected to generate evidence on mental health-related stigma in oncology settings and to identify educational and organisational strategies that may improve equity, inclusiveness, and quality of cancer care for patients living with mental disorders.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthcare professionals working in participating oncology centres.
  • Physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants.
  • Direct involvement in the clinical care of oncology patients.
  • Employed at one of the participating study sites at the time of enrolment.
  • Able to understand the study information and provide informed consent.
  • Willing to participate in the study.

For the qualitative phase, a purposive sample of participants will be selected from survey respondents who agree to be contacted for a semi-structured interview.

Exclusion criteria

  • Refusal to participate or failure to provide informed consent.
  • Students in training.
  • Healthcare personnel working in services with very limited patient contact and without direct responsibility for oncology patient care.

Treatment and study plan

OMS-HC Questionnaire and Semi-Structured Interviews

Other

Participants complete an anonymous questionnaire and, where selected, participate in a semi-structured interview for research data collection purposes. No clinical or behavioural intervention is administered.

Primary outcomes

  1. Mental health-related stigma among oncology healthcare professionals

    Time frame: At survey completion (up to 3 months)

    Level of stigma towards people with mental disorders measured using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC). The total score ranges from 15 to 75, with higher scores indicating greater stigma and lower scores indicating more positive attitudes towards people with mental disorders.

Secondary outcomes

  1. Factors Associated With OMS-HC Scores

    Time frame: Up to 3 months

    Association between OMS-HC scores and healthcare professionals' socio-demographic and professional characteristics, including age, sex, professional role, education, clinical area, years of experience, previous mental health experience, and perceived mental health training.

  2. Healthcare professionals' experiences and perceptions regarding oncology patients with mental disorders

    Time frame: Up to 9 months

    Qualitative themes identified through semi-structured interviews, including perceived barriers to care, diagnostic overshadowing, impact of psychiatric comorbidity on clinical decision-making, relational challenges, and facilitators to improve cancer care.

  3. Integrated mixed-method understanding of stigma towards oncology patients with mental disorders

    Time frame: Up to 13 months

    Integration of quantitative survey findings and qualitative interview data through joint displays and meta-inferences to provide a comprehensive understanding of mental health-related stigma among oncology healthcare professionals, including its determinants, manifestations, and perceived impact on cancer care delivery and clinical decision-making.

Study contacts

Contact information is provided by the study sponsor or research team.

Angela Grassi, PhD

CONTACT

[email protected]

+39 498215527

Carlo Alberto Camuccio, MSN; MSC

CONTACT

[email protected]

+39 3336173150

Sponsors and collaborators

Lead sponsor

Istituto Oncologico Veneto IRCCS

Other

Collaborators

  • Centro di Riferimento Oncologico - Aviano
  • Istituti Tumori Giovanni Paolo II

Registry information

Official study title

Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders: A Multicentre Mixed-Method Design Study

Acronym: ONCO-MinD

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 5, 2026
Registry last updated
Aug 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.